For infants whose initial sample is IgM nonnegative and Zika virus neutralizing antibodies are detected on either the infant’s specimen at birth or the mother’s specimen, PRNT at age ≥18 months might help confirm or rule out congenital Zika virus infection. This evidence concerns the gene CD40LG and Zika virus infectious disease.